RankingsPricing
  1. JP-listed companies
  2. KNC Laboratories Co., Ltd.
  3. Financials
  4. Cash and cash equivalents

KNC Laboratories Co., Ltd.JP:6568

Market cap
¥8.6B
P/E ratio
14.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 20252,386-27.96%
Mar 31, 20243,312+44.15%
Mar 31, 20232,297+16.40%
Mar 31, 20221,974+0.54%
Mar 31, 20211,963+32.96%
Mar 31, 20201,476-51.94%
Mar 31, 20193,072-43.25%
Mar 31, 20185,413+328.61%
Mar 31, 20171,263

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)